Burned by the lira

The lira had already declined 20% against the dollar on Friday - on a mixture of domestic financial problems and increasing friction with the US - and the decline continued this morning with the Turkish currency plumbing new lows. 

For the time being Turkey’s financial crisis looks localised but the country’s central bank has perhaps only days to stop the decline of the currency before the lira’s freefall results in loan defaults, starts seriously affecting the country’s financial system and potentially starts spilling over onto European banks. Into this domestically induced financial slide comes the deteriorating relationship between Turkey and the US. 

The US is holding it against Turkey, pointing to its refusing to support US sanctions against Iran and not releasing an American pastor who is being held on terrorism charges. The US response was fairly clear cut – on Friday when the lira was in free-fall the US announced it would raise the tariffs on imports of Turkish steel to 50% and the tariffs take effect Monday morning.

Oil slides on stronger dollar, Turkey contagion

Oil prices briefly perked up at the end of last week because the International Energy Agency said that sanctions against Iran could create supply problems later this year, but a firming of the dollar offset the move higher. With the start of the new week oil prices began moving downward again. The deterioration of the financial situation in Turkey played a part too, and contributed to the risk aversion across markets.  Brent crude is down 0.32% while the US listed West Texas Intermediate is trading 0.31% lower. 

On the currency markets both the pound and the euro are lower against the dollar, sterling trading down 0.31% and the common currency down 0.39%. 

Monsanto hit by $289 million bill over weed killer 

Monsanto, now under its new parent Bayer, will have to pay out almost $300 million for using an ingredient in its weed killer Roundup which is believed to be causing cancer. A San Francisco Court ruled on Friday in favour of the claimants in the first lawsuit of thousands which are due to go to trial over the coming months. Bayer shares are down 11%.